publicly traded companies glp-1 receptor agonist manufacturers 2 Poised to Capitalize on the Rise of Weight Loss Drugs GLP-1 Analogues Market Size, Share
Description
Sharma MK, Jalewa J, Holscher C
D.IshikawaM.LeeB
Table 10 summarizes the warnings and precautions listed in the labels for SGLT-2 inhibitors currently marketed in the U.S
1,2 Given that GLP-1 is a large protein, analogs are primarily administered via subcutaneous injection, with the exception of oral semaglutide 7 mg or 14 mg (Rybelsus, Novo Nordisk)
476 The study results suggest that semaglutide may be a more suitable choice for patients with severe insulin deficiency, while dapagliflozin might be effective for a broader range of patients with metabolic abnormalities
